7726 Stock Overview
Carilex Medical, Inc. engages in the research and development, manufacture, and sale of medical devices for wound care management worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Carilex Medical, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$58.40 |
| 52 Week High | NT$82.90 |
| 52 Week Low | NT$54.80 |
| Beta | 0 |
| 1 Month Change | 6.18% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -19.78% |
Recent News & Updates
Recent updates
Shareholder Returns
| 7726 | TW Medical Equipment | TW Market | |
|---|---|---|---|
| 7D | 1.4% | 2.7% | 1.3% |
| 1Y | n/a | 4.9% | 29.2% |
Return vs Industry: Insufficient data to determine how 7726 performed against the TW Medical Equipment industry.
Return vs Market: Insufficient data to determine how 7726 performed against the TW Market.
Price Volatility
| 7726 volatility | |
|---|---|
| 7726 Average Weekly Movement | 8.6% |
| Medical Equipment Industry Average Movement | 4.2% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in TW Market | 8.7% |
| 10% least volatile stocks in TW Market | 2.3% |
Stable Share Price: 7726's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine 7726's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1985 | n/a | n/a | www.carilexmedical.com |
Carilex Medical, Inc. engages in the research and development, manufacture, and sale of medical devices for wound care management worldwide. It offers support surfaces, chair cushions, and negative pressure wound therapy products to prevent and manage pressure sores and wounds. The company was founded in 1985 and is headquartered in Taoyuan, Taiwan.
Carilex Medical, Inc. Fundamentals Summary
| 7726 fundamental statistics | |
|---|---|
| Market cap | NT$1.19b |
| Earnings (TTM) | NT$0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs 7726 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 7726 income statement (TTM) | |
|---|---|
| Revenue | NT$0 |
| Cost of Revenue | NT$0 |
| Gross Profit | NT$0 |
| Other Expenses | NT$0 |
| Earnings | NT$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did 7726 perform over the long term?
See historical performance and comparison